Literature DB >> 22971029

Improving the managed entry of new medicines: sharing experiences across Europe.

Brian Godman1, Ken Paterson, Rickard E Malmström, Gisbert Selke, Jean-Paul Fagot, Jana Mrak.   

Abstract

The 3-day course on the managed entry of new medicines was run by the Piperska group, which is a pan-European group striving to enhance the health of the public as a whole and the individual patient through exchanging ideas and research around the rational use of drugs. Participants included health authority and health insurance personnel, academics and those from commercial organizations. The principal aim of the conference was to bring together people to discuss ways to improve the managed entry of new drugs.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22971029     DOI： 10.1586/erp.12.44

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN： 1473-7167            Impact factor:   2.217


  12 in total

1.  Interface management of pharmacotherapy. Joint hospital and primary care drug recommendations.

Authors:  Linda Björkhem-Bergman; Eva Andersén-Karlsson; Richard Laing; Eduardo Diogene; Oyvind Melien; Malena Jirlow; Rickard E Malmström; Sabine Vogler; Brian Godman; Lars L Gustafsson
Journal:  Eur J Clin Pharmacol       Date:  2013-05-03       Impact factor: 2.953

Review 2.  Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs.

Authors:  Brian Godman; Rickard E Malmström; Eduardo Diogene; Sisira Jayathissa; Stuart McTaggart; Thomas Cars; Samantha Alvarez-Madrazo; Christoph Baumgärtel; Anna Brzezinska; Anna Bucsics; Stephen Campbell; Irene Eriksson; Alexander Finlayson; Jurij Fürst; Kristina Garuoliene; Iñaki Gutiérrez-Ibarluzea; Krystyna Hviding; Harald Herholz; Roberta Joppi; Marija Kalaba; Ott Laius; Kamila Malinowska; Hanne B Pedersen; Vanda Markovic-Pekovic; Jutta Piessnegger; Gisbert Selke; Catherine Sermet; Susan Spillane; Dominik Tomek; Luka Vončina; Vera Vlahović-Palčevski; Janet Wale; Magdalena Wladysiuk; Menno van Woerkom; Corinne Zara; Lars L Gustafsson
Journal:  Front Pharmacol       Date:  2014-06-10       Impact factor: 5.810

Review 3.  Design and delivery of a tailored intervention to implement recommendations for multimorbid patients receiving polypharmacy into primary care practices.

Authors:  Cornelia Jäger; Joachim Szecsenyi; Jost Steinhäuser
Journal:  Biomed Res Int       Date:  2015-01-05       Impact factor: 3.411

4.  Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways.

Authors:  Michael Ermisch; Anna Bucsics; Patricia Vella Bonanno; Francis Arickx; Alexander Bybau; Tomasz Bochenek; Marc van de Casteele; Eduardo Diogene; Jurij Fürst; Kristina Garuolienė; Martin van der Graaff; Jolanta Gulbinovič; Alan Haycox; Jan Jones; Roberta Joppi; Ott Laius; Irene Langner; Antony P Martin; Vanda Markovic-Pekovic; Laura McCullagh; Einar Magnusson; Ellen Nilsen; Gisbert Selke; Catherine Sermet; Steven Simoens; Robert Sauermann; Ad Schuurman; Ricardo Ramos; Vera Vlahovic-Palcevski; Corinne Zara; Brian Godman
Journal:  Front Pharmacol       Date:  2016-09-28       Impact factor: 5.810

5.  The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications.

Authors:  Alessandra Ferrario; Diāna Arāja; Tomasz Bochenek; Tarik Čatić; Dávid Dankó; Maria Dimitrova; Jurij Fürst; Ieva Greičiūtė-Kuprijanov; Iris Hoxha; Arianit Jakupi; Erki Laidmäe; Olga Löblová; Ileana Mardare; Vanda Markovic-Pekovic; Dmitry Meshkov; Tanja Novakovic; Guenka Petrova; Maciej Pomorski; Dominik Tomek; Luka Voncina; Alan Haycox; Panos Kanavos; Patricia Vella Bonanno; Brian Godman
Journal:  Pharmacoeconomics       Date:  2017-12       Impact factor: 4.981

6.  Availability and Affordability of Drugs With a Conditional Approval by the European Medicines Agency; Comparison of Korea With Other Countries and the Implications.

Authors:  Hye-Young Kwon; Hyungmin Kim; Brian Godman
Journal:  Front Pharmacol       Date:  2018-09-03       Impact factor: 5.810

7.  Confidentiality agreements: a challenge in market regulation.

Authors:  Roberto F Iunes; Manuela Villar Uribe; Janet Bonilla Torres; Marina Morgado Garcia; Carolina Zampirolli Dias; Juliana Alvares-Teodoro; Francisco de Assis Acurcio; Augusto Afonso Guerra-Junior
Journal:  Int J Equity Health       Date:  2019-06-03

8.  Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.

Authors:  Rickard E Malmström; Brian B Godman; Eduard Diogene; Christoph Baumgärtel; Marion Bennie; Iain Bishop; Anna Brzezinska; Anna Bucsics; Stephen Campbell; Alessandra Ferrario; Alexander E Finlayson; Jurij Fürst; Kristina Garuoliene; Miguel Gomes; Iñaki Gutiérrez-Ibarluzea; Alan Haycox; Krystyna Hviding; Harald Herholz; Mikael Hoffmann; Saira Jan; Jan Jones; Roberta Joppi; Marija Kalaba; Christina Kvalheim; Ott Laius; Irene Langner; Julie Lonsdale; Sven-Äke Lööv; Kamila Malinowska; Laura McCullagh; Ken Paterson; Vanda Markovic-Pekovic; Andrew Martin; Jutta Piessnegger; Gisbert Selke; Catherine Sermet; Steven Simoens; Cankat Tulunay; Dominik Tomek; Luka Vončina; Vera Vlahovic-Palcevski; Janet Wale; Michael Wilcock; Magdalena Wladysiuk; Menno van Woerkom; Corrine Zara; Lars L Gustafsson
Journal:  Front Pharmacol       Date:  2013-05-14       Impact factor: 5.810

Review 9.  Personalizing health care: feasibility and future implications.

Authors:  Brian Godman; Alexander E Finlayson; Parneet K Cheema; Eva Zebedin-Brandl; Inaki Gutiérrez-Ibarluzea; Jan Jones; Rickard E Malmström; Elina Asola; Christoph Baumgärtel; Marion Bennie; Iain Bishop; Anna Bucsics; Stephen Campbell; Eduardo Diogene; Alessandra Ferrario; Jurij Fürst; Kristina Garuoliene; Miguel Gomes; Katharine Harris; Alan Haycox; Harald Herholz; Krystyna Hviding; Saira Jan; Marija Kalaba; Christina Kvalheim; Ott Laius; Sven-Ake Lööv; Kamila Malinowska; Andrew Martin; Laura McCullagh; Fredrik Nilsson; Ken Paterson; Ulrich Schwabe; Gisbert Selke; Catherine Sermet; Steven Simoens; Dominik Tomek; Vera Vlahovic-Palcevski; Luka Voncina; Magdalena Wladysiuk; Menno van Woerkom; Durhane Wong-Rieger; Corrine Zara; Raghib Ali; Lars L Gustafsson
Journal:  BMC Med       Date:  2013-08-13       Impact factor: 8.775

10.  Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions.

Authors:  Mohamed Gad; Ahmed Salem; Wija Oortwijn; Ruaraidh Hill; Brian Godman
Journal:  Front Pharmacol       Date:  2020-03-03       Impact factor: 5.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.